DMED — Diagnamed Holdings Income Statement
0.000.00%
Last trade - 00:00- CA$2.90m
- CA$2.79m
- 14
- 16
- 37
- 10
Annual income statement for Diagnamed Holdings, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 1.95 | 1.13 | 1.28 | 0.501 |
| Operating Profit | -1.95 | -1.13 | -1.28 | -0.501 |
| Net Income Before Taxes | -1.95 | -1.13 | -1.28 | -0.501 |
| Net Income After Taxes | -1.95 | -1.13 | -1.28 | -0.501 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -1.95 | -1.13 | -1.28 | -0.501 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -1.95 | -1.13 | -1.28 | -0.501 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.026 | -0.015 | -0.016 | -0.009 |